chr15-33701040-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The ENST00000634891.2(RYR3):āc.6443A>Gā(p.Asn2148Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,613,322 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ). Synonymous variant affecting the same amino acid position (i.e. N2148N) has been classified as Benign.
Frequency
Consequence
ENST00000634891.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RYR3 | NM_001036.6 | c.6443A>G | p.Asn2148Ser | missense_variant | 42/104 | ENST00000634891.2 | NP_001027.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RYR3 | ENST00000634891.2 | c.6443A>G | p.Asn2148Ser | missense_variant | 42/104 | 1 | NM_001036.6 | ENSP00000489262 | P4 | |
RYR3 | ENST00000389232.9 | c.6443A>G | p.Asn2148Ser | missense_variant | 42/104 | 5 | ENSP00000373884 | A1 | ||
RYR3 | ENST00000415757.7 | c.6443A>G | p.Asn2148Ser | missense_variant | 42/103 | 2 | ENSP00000399610 | A2 | ||
RYR3 | ENST00000634418.1 | c.6443A>G | p.Asn2148Ser | missense_variant | 42/102 | 5 | ENSP00000489529 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000805 AC: 2AN: 248326Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134646
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1461158Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 726748
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152164Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74336
ClinVar
Submissions by phenotype
Epileptic encephalopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 15, 2020 | This sequence change replaces asparagine with serine at codon 2148 of the RYR3 protein (p.Asn2148Ser). The asparagine residue is highly conserved and there is a small physicochemical difference between asparagine and serine. This variant is present in population databases (rs200035756, ExAC 0.01%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with RYR3-related disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at